Breaking News

Harlan Labs Appoints BD Director

By Kristin Brooks | February 4, 2014

Guptato to head RMS Business Unit

Urvashi Gupta has been appointed director of business development for Harlan Laboratories Research Models and Services (RMS) business unit in Asia. Ms. Gupta will focus on expanding Harlan's market position and new business initiatives, including key strategic partnerships and leading corporate development efforts. She will also oversee a team of business development managers in Japan and Korea, and will have responsibility for agents in China, Singapore, Hong Kong, Malaysia and Australia.
Ms. Gupta has 13 years of experience in research, operations, client relations and sales throughout Asia, Europe and the U.S. Most recently, she served as business development manager for Covance, where she was responsible for all sales initiatives in India with a focus on expanding the company's presence throughout the region. She also worked as an operations manager and research scientist with Covance.

"As the preclinical research market continues to establish roots and grow outside of North America and Europe, now is the perfect time to expand our already talented business development group," said Stuart Frith, global vice president of business development at Harlan Laboratories. "We're excited to add Urvashi to our team, and her wealth of international experience in the CRO and pharmaceutical industries will be an asset to Harlan as we continue to expand in Asia."  
blog comments powered by Disqus
  • The Role of Value in Drug Pricing

    The Role of Value in Drug Pricing

    Keren Shani, Ryan Million, Trinity Partners ||October 11, 2016
    Exploring the trend of using frameworks and models to evaluate the value of a drug

  • CRO-Sponsor Partnerships

    CRO-Sponsor Partnerships

    Craig Morgan, Brand Development Director, goBalto Inc.||October 11, 2016
    10 tips for enabling better CRO and sponsor collaborations

  • The Human Parts of Mouse Models

    The Human Parts of Mouse Models

    Julia Schueler, Head of in vivo Operations, Oncotest, a Charles River company ||October 11, 2016
    The PDX model system has come back into focus